"摘要赏析"标签列表

[APASL2013]脂联素通过TIMP-1和CD63介导FAK活性以调节肝星状细胞的侵袭性2013-06-14

[APASL2013]Adiponectin Mediates Hepatic Stellate Cell Invasion through TIMP-1 and CD63 Regulation of FAK Activity2013-06-14

[APASL2013]Development of a New Non-Invasive Fibrosis Test for Chronic Hepatitis B Patients and Comparison with Other Scores2013-06-14

[APASL2013]新的口服铁鳌合剂地拉罗司可抑制肝硬化大鼠的纤维化和癌前病变2013-06-14

[APASL2013]The New Oral Iron Chelator Deferasirox Prevents Liver Fibrosis and Preneoplastic Lesions in Rat Liver Cirrhosis2013-06-14

[APASL2013]地拉罗司在Mdr2-/-小鼠中无抗纤维化活性2013-06-14

[APASL2013]Deferasirox Does Not Exhibit Antifibrotic Activity when Administered to Mdr2-/- Mice2013-06-14

[APASL2013]Hepatic Vein Arrival Times Using a Microbubble Contrast Ultrasonography Can Predict Disease Severity Non-invasively in Patients with Alcoholic Liver Disease2013-06-14

[APASL2013]Superiority of ROADMAP strategy in HBeAg Positive CHB Patients: 2 year final result of EFFORT study2013-06-09

[APASL2013]Peginterferon Lambda for the Treatment of HBeAg-Positive Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa2013-06-09

[APASL2013]HBV DNA Seroclearance Significantly Increases Rates of Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients with Low Viral Loads2013-06-09

[APASL2013]A Clinical Trial on Anti-HBV-DC Vaccine Combined with Thymosin-α1 in the Inactive HBsAg Carriers2013-06-09

[APASL2013]非活动性HBsAg携带者抗HBV-DC疫苗联合胸腺肽α1治疗的临床试验2013-06-09

[APASL2013]A 96-week Randomized Trial of Switching to Entecavir in Chronic Hepatitis B Patients with a Complete Virologic Response to Lamivudine2013-06-08

[APASL2013]A Randomized， Three-arm Study to Optimize Lamivudine Efficacy in HBeAg Positive Chronic Hepatitis B (CHB) Patients: Week-72 EXPLORE Study Results2013-06-08

[APASL2013]Comparison of Telbivudine Alone and in Combination with Thymosin-α1 in HBeAg-positive Chronic Hepatitis B2013-06-08

[APASL2013]S-Collate Cohort Study: Early On-treatment HBsAg Decline in ’Real Life’ Predicts HBsAg Clearance Post-treatment in Peginterferon Alfa-2a (40KD)-treated HBeAg-negative Patients2013-06-08

[APASL2013]S-Collate队列研究：“现实生活”中HBsAg的早期治疗下降预测聚乙二醇干扰素α-2a (40KD)治疗HBeAg阴性患者的HBsAg清除2013-06-08

[APASL2013]Combination of Lamivudine and Adefovir Initial Therapy and Lamivudine and Entecavir Monotherapy in Hepatitis B e Antigen-positive Chronic Hepatitis B2013-06-07

[APASL2013]Entecavir versus Other Standard-of-Care for up to 4 Years in Nucleos(t)ide-naïve Patients with CHB in a Chinese Clinical Practice Setting2013-06-07